Literature DB >> 3709810

TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids.

K Takamizawa, M Iwamori, S Kozaki, G Sakaguchi, R Tanaka, H Takayama, Y Nagai.   

Abstract

The receptor structure of Clostridium botulinum neurotoxin type A was analysed by TLC immunostaining. GQ1b was found to be the most potent receptor, and the neurotoxin also bound to GT1b and GD1a, but not to GM3, GM2, GM1, GD3, GD1b and GT1a. Optimum binding of neurotoxin to the ganglioside appeared in 0.01 M phosphate buffer (pH 7.2) containing 0.2% NaCl. Higher and lower NaCl concentrations diminished neurotoxin binding to the ganglioside. In addition, the neurotoxin was able to bind to free fatty acids. Maximum binding was observed on stearic acid and neurotoxin binding to free fatty acids was not affected by NaCl concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709810     DOI: 10.1016/0014-5793(86)80614-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.

Authors:  Michael C Brothers; Mengfei Ho; Ram Maharjan; Nathan C Clemons; Yuka Bannai; Mark A Waites; Melinda J Faulkner; Theresa B Kuhlenschmidt; Mark S Kuhlenschmidt; Steven R Blanke; Chad M Rienstra; Brenda A Wilson
Journal:  FEBS J       Date:  2011-10-20       Impact factor: 5.542

2.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 3.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Activities of Aeromonas hydrophila hemolysins and their interaction with erythrocyte membranes.

Authors:  S Kozaki; K Kato; T Asao; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Clinical Pharmacology of Botulinum Toxin Drugs.

Authors:  Dirk Dressler
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Binding of botulinum neurotoxin to pure cholinergic nerve terminals isolated from the electric organ of Torpedo.

Authors:  J Blasi; G Egea; M J Castiella; M Arribas; C Solsona; P J Richardson; J Marsal
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Enhancing the protective immune response against botulism.

Authors:  Amanda Przedpelski; William H Tepp; Abby R Kroken; Zhuji Fu; Jung-Ja P Kim; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

10.  Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin.

Authors:  Masao Iwamori; Kotarou Takamizawa; Mikio Momoeda; Yuriko Iwamori; Yuji Taketani
Journal:  Glycoconj J       Date:  2008-05-23       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.